Carrick Therapeutics

📍 Dublin, Ireland🗓 Founded 2015👥 19 employees💰 Last funded Oct 2016
Biotechnology Research🌐 carricktherapeutics.com
Website LinkedIn
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in Carrick Therapeutics?
Carrick Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Carrick Therapeutics last raise funding?
The most recent investment in Carrick Therapeutics recorded on gritt.io was in October 2016.
When was Carrick Therapeutics founded?
Carrick Therapeutics was founded in 2015.
What industry is Carrick Therapeutics in?
Carrick Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Carrick Therapeutics based?
Carrick Therapeutics is headquartered in Dublin, Ireland.